Christina Baker
Physician Assistant · Massillon, OHNPI 1619402070
Payments from drug & device makers
Across 216 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$698
- Novo Nordisk$259
- Pfizer$255
- Daiichi Sankyo Inc.$224
- Johnson & Johnson$219
- Bayer$163
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,395100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$118
How this compares
$3,409 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 38 | $40,101 |
| EliquisApixaban | 35 | $36,665 |
| RybelsusSemaglutide | 21 | $32,402 |
| MounjaroTirzepatide | 27 | $32,038 |
| TrulicityDulaglutide | 26 | $31,546 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 44 | $29,730 |
| FarxigaDapagliflozin Propanediol | 15 | $13,471 |
| LinzessLinaclotide | 14 | $8,325 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $2,894 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 72 | $1,416 |
| Fluticasone Propionate | 55 | $1,241 |
| Duloxetine Hcl | 41 | $1,006 |
| Pregabalin | 32 | $874 |
| Gabapentin | 34 | $799 |
| Rosuvastatin Calcium | 47 | $632 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $134 | $63,58453 claims |
| Boehringer IngelheimJardiance | $123 | $40,10138 claims |
| PfizerEliquis | $255 | $36,66535 claims |
| Novo NordiskRybelsus | $259 | $32,40221 claims |
| GSKTrelegy Ellipta | $129 | $29,73044 claims |
| AstraZenecaFarxiga, Symbicort | $63 | $16,36529 claims |
| AbbVieLinzess | $698 | $8,32514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Massillon
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alan OdonnellCincinnati$71K
- Brook GramBeloit$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.